Meta-Analysis of the Effect of Kangfuxin Liquid on Diabetic Patients with Skin Ulcers

Table 1

The basic characteristics of inclusion in the literature.

Study	Year	Sample time (year.month)	Cases treat/Con	Age (years)		Sex ratio (male/female)		Course of disease (years)		Study design	Outcome measures
				Treatment group	Control group	Treatment group	Control group	Treatment group	Control group
Ling [5]	2020	2018.8∼2019.7	40/40	72.51 ± 1.72	72.45 ± 1.63	25/15	24/16	6.71 ± 1.25	6.68 ± 1.23	RCT	① + ② + ③
Yu-zhi et al. [14]	2010	2007.8∼2008.10	42/40	49 ± 17	48 ± 16	24/18	24/16	7.2 ± 5.1	7.11 ± 4.9	RCT	① + ②
Zhiguo [15]	2019	2018.8∼2019.8	36/36	72.2 ± 8.1	71.6 ± 7.5	20/16	22/14	2.1 ± 0.1	2.3 ± 0.4	RCT	① + ② + ③
Jian-zhong et al. [16]	2018	2014.2∼2018.2	48/48	72.4 ± 8.1	73.3 ± 8.7	27/21	27/21	NR	NR	RCT	① + ② + ③
Congxiang [17]	2014	2010.11∼2012.11	30/30	62.6 ± 44.3	62.3 ± 19.8	20/10	18/12	12.2 ± 4.5	12.0 ± 4.7	RCT	①
Jian et al. [18]	2016	2014.6∼2016.6	60/60	60.78 ± 10.15	61.25 ± 10.02	31/29	30/30	NR	NR	RCT	①
Wenyao et al. [19]	2019	2018.2∼2019.6	30/30	65.33 ± 9.58	64.40 ± 11.21	17/13	18/12	14.20 ± 5.85	13.50 ± 5.53	RCT	① + ② + ③
Xiao-yan [20]	2014	2007∼2010	50/50	NR	NR	28/22	26/24	NR	NR	RCT	① + ②
Honglin and Anyuan [21]	2019	2016.5∼2017.9	50/50	50.40 ± 1.92	50.14 ± 1.53	29/21	30/20	10.87 ± 3.64	11.37 ± 3.58	RCT	① + ② + ③
Xiangjiao [22]	2017	2014.2∼2015.10	21/20	56.7 ± 9.8	55.1 ± 10.7	13/8	11/9	5.1 ± 1.9	5.1 ± 1.9	RCT	① + ②
Wenpeng et al. [23]	2011	NR	33/30	29∼50	29∼50	NR	NR	1.5∼26	1.5∼26	RCT	① + ②

Note. Treat: treatment; Con: control; RCT: randomized controlled trial; NR: not reported; ①: total effective rate; ②: cure time; ③: length of stay.